Trauma fixation devices are used for treatment of internal injuries, such as dislocations, fractures, bruises and external injuries, burns, cuts, and others such injuries. Internal fixation devices are implanted into the body for the stabilization of severe fractures and dislocations, and deformity correction procedures. Whereas, external fixation devices are used to hold the bone in place by means of an external frame in cases of open fractures, severe soft tissue damage and burn injuries. These devices help to align fractured bones, prevent improper bone recovery, promote faster healing of external injuries, and complete repair of internal injuries. In the current market scenario, the increasing participation in sports opens up new avenues for trauma fixation devices market.
The North America trauma fixation market is expected to witness a surge in the future due to the rising count of geriatric patients suffering from osteoporosis and other bone diseases, increasing incidents of road and burn accidents cases. In addition, the increasing investments by governments agencies and multinational companies would augment the market growth. Furthermore, the availability of advanced medical facilities, favorable reimbursement policies and high healthcare expenditure are expected to drive the market growth. On the other hand, factors such as high cost of surgeries, competitive pricing, and availability of substitutes would restrain the market growth. The demand for improved facilities in trauma surgeries has led manufacturers to focus on developing products that are less invasive and more anatomical, such as low-profile plating system for extremity fixation procedures and Polyaxial plating system for improving screw placement. The increasing participation in sports opens up new avenues for trauma fixation devices market.
The North America trauma fixation devices market is segmented based on types, end users, and country. Based on type, the trauma fixation devices market is segmented into internal fixation devices and external fixation devices. The internal fixation device market is further sub-segmented into screws, rods, plates, nails and wires. On the basis of end users, the market is divided into hospitals, point of care testing, and others (ambulatory care units, emergency units, and trauma centers) . Geographic breakdown and deep analysis of each of the aforesaid segments is included for United States, Canada, and Mexico.The key market payers of the North America trauma fixation devices market profiled in the report include Stryker Corporation, Zimmer Holdings Inc., DePuy Synthes (Companies of Johnson & Johnson), Smith & Nephew PLC, Tornier Inc., and Biomet Inc. among others. The leading companies have implemented new product launches, mergers and acquisitions as few of the key developmental strategies, with a view to gain a stronger foothold in the North America trauma fixation device market.
KEY BENEFITS FOR STAKEHOLDERS:
The report offers a detailed analysis of key driving and restraining factors of the North America trauma fixation devices market.This report offers an in-depth quantitative analysis of the current market and estimations through 2015-2020, which assists in identifying the prevailing market opportunities.An extensive analysis of market shares for each segment helps in understanding the current trend of market.The key manufacturers within the North America trauma fixation devices market are profiled in the report and their strategies are analyzed thoroughly.Geographically, the North America trauma fixation devices market is segmented into United States, Canada, and Mexico.
KEY MARKET SEGMENTS:
North America Trauma Fixation Devices Market By Type
Internal Fixation Devices - By Type
External Fixation Devices - By technology
North America Trauma Fixation Devices Market By End Users
North America Trauma Fixation Devices Market By Country
The Global Cetirizine Hydrochloride market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Cetirizine Hydrochloride market, especially in North America, Europe, Asia-Pacific, South America, Middle ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and Philippines, focuses ...
November 2017 | $4660 |View Details>>
In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include UCB Pharma Pfizer J ...
November 2017 | $3360 |View Details>>
In 2016, the Europe Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in ...
November 2017 | $4660 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research